Goldman Sachs Starts Allison Transmission (ALSN) at Neutral
Get Alerts ALSN Hot Sheet
Price: $116.24 -1.6%
Rating Summary:
6 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Rating Summary:
6 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Join SI Premium – FREE
Goldman Sachs initiates coverage on Allison Transmission (NYSE: ALSN) with a Neutral. PT $25.00.
The firm calls ALSN "an intriguing value story with a dominant market position, sustainable, best-in-class margins, priced at a 13% free cash flow yield." That said, they see a mixed cyclical outlook as North America trucker returns and capex are now at mid-cycle and lead times have contracted. Also military vehicle demand is in the early stages of a sharp multi-year downturn and the the US pressure pumping industry faces near-term over-supply.
For an analyst ratings summary and ratings history on Allison Transmission click here. For more ratings news on Allison Transmission click here.
Shares of Allison Transmission closed at $21.90 yesterday.
The firm calls ALSN "an intriguing value story with a dominant market position, sustainable, best-in-class margins, priced at a 13% free cash flow yield." That said, they see a mixed cyclical outlook as North America trucker returns and capex are now at mid-cycle and lead times have contracted. Also military vehicle demand is in the early stages of a sharp multi-year downturn and the the US pressure pumping industry faces near-term over-supply.
For an analyst ratings summary and ratings history on Allison Transmission click here. For more ratings news on Allison Transmission click here.
Shares of Allison Transmission closed at $21.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Sutro Biopharma (STRO) at Buy
- CLSA Starts True Corp PCL (TRUE:TB) at Outperform (2)
- TD Cowen Starts Obsidian Therapeutics (OBX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share